Sara M. Nayeem, M.D. is Executive Vice President, Investments at Enavate Sciences . Dr. Nayeem serves an integral role in the origination, evaluation, and selection of Enavate investments, as well as supports Enavate partner companies on governance, partnerships, fundraising, and other strategic initiatives. Dr. Nayeem has 20 years of banking and institutional investing experience. She most recently served as Partner at Avoro Ventures, a biopharma venture fund she helped launch in 2021. Previously, she was a Partner at New Enterprise Associates, Inc. (NEA), where she spent 12 years as part of the biopharma investing group. Prior to joining NEA, Dr. Nayeem was an Associate with Merrill Lynch's Global Healthcare Group, where she advised biotechnology and medical device companies. She began her career as an Investment Banking Analyst at Morgan Stanley. Dr. Nayeem earned her AB in Biology from Harvard and concurrent M.D./MBA degrees from Yale University. She serves on the boards of the New England Venture Capital Association, No Patient Left Behind, Incubate Coalition, and on the Advisory Board for The Blavatnik Fund for Innovation at Yale.